Cimatron Ltd. (CIMT) Reports Non-GAAP Net Profit of $1 Million in the Fourth Quarter of 2009
Feb. 22, 2010 (PR Newswire) — Cimatron Reports Non-GAAP Net Profit of $1 Million in the Fourth Quarter of 2009
GIVAT SHMUEL, Israel, February 22, 2010 /PRNewswire-FirstCall/ — Cimatron Limited (NASDAQ: CIMT) (“Cimatron” or the “Company”), a leading provider of integrated CAD/CAM solutions for the toolmaking and manufacturing industries, today announced financial results for the fourth quarter and full year 2009.
The following provides details on Cimatron’s GAAP and non-GAAP results for the fourth quarter and full year 2009:
GAAP:
Revenues for the fourth quarter of 2009 were $9.8 million, compared to $10.4 million recorded in the fourth quarter of 2008. In the full year ended December 31, 2009, revenues were $33 million, compared to $41 million in 2008.
Gross Profit for the fourth quarter of 2009 was $8 million as compared to $8.3 million for the same period in 2008. Gross margin in the fourth quarter of 2009 was 82% of revenues, compared to a gross margin of 79% in the fourth quarter of 2008. In 2009, gross profit was $26.8 million, compared to $33.2 million in 2008. Gross margin in 2009 constituted 81% of revenues, reflecting no change relative to 2008.
Operating Profit in the fourth quarter of 2009 was $773 thousand, compared to an operating profit of $652 thousand in the fourth quarter of 2008. In 2009, Cimatron recorded an operating loss of $(957) thousand, compared to an operating profit of $526 thousand in 2008.
Net Profit for the fourth quarter of 2009 was $1.4 million, or $0.15 per diluted share, compared to a net profit of $706 thousand, or $0.08 per diluted share recorded for the same quarter of 2008.
In 2009, net profit was $14 thousand, or $0.00 per diluted share, compared to a net profit of $724 thousand, or $0.08 per diluted share, in 2008.
Non-GAAP:
Revenues on a non-GAAP basis for the fourth quarter of 2009 were $9.8 million, compared to $10.5 million recorded for the fourth quarter of 2008. In the full year ended December 31, 2009, revenues were $33 million, compared to $41.8 million in 2008.
Gross Profit on a non-GAAP basis for the fourth quarter of 2009 was $8.2 million as compared to $8.5 million for the same period in 2008. Gross margin in the fourth quarter of 2009 was 84% of revenues, compared to 81% in the fourth quarter of 2008. In 2009, gross profit on a non-GAAP basis was $27.4 million, compared to $34.6 million in 2008. Gross margin on a non-GAAP basis in 2009 constituted 83% of revenues, reflecting no change relative to 2008.
Operating Profit on a non-GAAP basis in the fourth quarter of 2009 was $1 million, compared to an operating profit of $977 thousand in the fourth quarter of 2008. In 2009, Cimatron recorded an operating profit of $31 thousand, compared to operating profit of $2.3 million in 2008.
Net Profit on a non-GAAP basis for the fourth quarter of 2009 was $955 thousand, or $0.10 per diluted share, compared to net profit of $553 thousand, or $0.06 per diluted share recorded in the same quarter of 2008. In 2009, net profit was $46 thousand, or $0.01 per diluted share, compared to net profit of $2.2 million, or $0.23 per diluted share, in 2008.
Commenting on the results, Danny Haran, President and Chief Executive Officer of Cimatron, said “We are very pleased with the fourth quarter results. The combination of higher revenues (relative to previous quarters in 2009) and continued tight budget control has resulted in a strong bottom line in the fourth quarter, and positive cash flow for the entire year. 2009 was one of the toughest years for our industry, ever. In spite of a steep drop in global demand, we were able to generate a significant amount of cash in 2009, and even show small non-GAAP operating and net profits for the year. We are confident that our strong market position, strong balance sheet, and healthy cash reserves, together with continued investment in marketing and product development, will help us take advantage of new business opportunities. We are witnessing some signs of market recovery, and look forward to a hopefully less turbulent 2010”, concluded Mr. Haran.
Conference Call
Cimatron’s management will host a conference call tomorrow, February 23rd, 2010 at 9:00 EST, 16:00 Israel time. On the call, management will review and discuss the results, and will answer questions by investors.
To participate, please call one of the following teleconferencing numbers. Please begin placing your call at least 5 minutes before the conference call commences.
USA: +1-800-994-4498
International: +972-3-9180644
Israel: 03-9180644
For those unable to listen to the live call, a replay of the call will be available from the day after the call at the investor relations section of Cimatron’s website, at: http://www.cimatron.com
Reconciliation between results on a GAAP and Non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income included herein. Non-GAAP financial measures consist of GAAP financial measures adjusted to include recognition of deferred revenues of acquired companies and to exclude amortization of acquired intangible assets and deferred income tax, as well as certain business combination accounting entries. The purpose of such adjustments is to give an indication of our performance exclusive of non-GAAP charges and other items that are considered by management to be outside our core operating results. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.
Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. We believe that these non-GAAP measures help investors to understand our current and future operating performance, especially as our two most recent acquisitions have resulted in amortization and non-cash items that have had a material impact on our GAAP results. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies.
About Cimatron
With over 25 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers, as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles, enable collaboration with outside vendors, and ultimately shorten product delivery time.
The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron’s subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.
Cimatron is publicly traded on the NASDAQ exchange under the symbol CIMT. For more information, please visit the company web site at: http://www.cimatron.com.
Safe Harbor Statement
This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act Of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to the Company’s plans, objectives and expected financial and operating results. The words “may,” “could,” “would,” “will,” “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycle, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties of the business, refer to the Company’s filings with the Securities and Exchanges Commission. The Company cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
CIMATRON LIMITED
CONSOLIDATED STATEMENTS OF INCOME
(US Dollars in thousands, except for per share data)
Three months ended Twelve months ended
December 31, December 31,
2009 2008 2009 2008
Total revenue 9,762 10,404 32,957 40,975
Total cost of revenue 1,719 2,142 6,186 7,769
Gross profit 8,043 8,262 26,771 33,206
Research and development
expenses, net 1,347 1,657 5,736 6,930
Selling, general and
administrative expenses 5,923 5,953 21,992 25,750
Operating income (loss) 773 652 (957) 526
Financial income
(expenses), net. 38 (207) 19 (80)
Taxes on Income 639 263 949 237
Other (41) 5 (41) -
Net income (loss) 1,409 713 (30) 683
Less: Net loss (gain)
attributable to the
noncontrolling interest (18) (*)(7) 44 (*)41
Net income attributable to
Cimatron's shareholders $ 1,391 $ 706 $ 14 $ 724
Net income per share -
basic and diluted $ 0.15 $ 0.08 $ 0.00 $ 0.08
Weighted average number of
shares outstanding
Basic EPS
(in thousands) 9,128 9,274 9,156 9,341
Diluted EPS
(in thousands) 9,128 9,274 9,156 9,360
(*) Reclassification due to the adoption of SFAS 160
CIMATRON LIMITED
RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
(US Dollars in thousands, except for per share data)
Three months ended
December 31,
2009 2008
GAAP Adj. NON-GAAP GAAP Adj. NON-GAAP
Total revenue (1) 9,762 - 9,762 10,404 77 10,481
Total cost of
revenue (2) 1,719 (147) 1,572 2,142 (148) 1,994
Gross profit 8,043 147 8,190 8,262 225 8,487
Research and
development expenses,
net 1,347 - 1,347 1,657 - 1,657
Selling, general and
administrative
expenses (2) 5,923 (100) 5,823 5,953 (100) 5,853
Operating income
(loss) 773 247 1,020 652 325 977
Financial income
(expenses), net. 38 - 38 (207) - (207)
Taxes on Income (3) 639 (726) (87) 263 (478) (215)
Other (4) (41) 43 2 5 - 5
Net income (loss) 1,409 (436) 973 713 (153) 560
Less: Net loss
(gain) attributable
to the noncontrolling
interest (18) - (18) (*)(7) - (*) (7)
Net income (loss)
attributable to
Cimatron's
shareholders $ 1,391 $ (436) $ 955 $ 706 $(153) $ 553
Net income per share
- basic and diluted $ 0.15 $ 0.10 $ 0.08 $ 0.06
Weighted average
number of shares
outstanding
Basic EPS
(in thousands) 9,128 9,128 9,274 9,274
Diluted EPS
(in thousands) 9,128 9,128 9,274 9,274
Twelve months ended
December 31,
2009 2008
GAAP Adj. NON-GAAP GAAP Adj. NON-GAAP
Total revenue (1) 32,957 - 32,957 40,975 821 41,796
Total cost of
revenue (2) 6,186 (588) 5,598 7,769 (588) 7,181
Gross profit 26,771 588 27,359 33,206 1,409 34,615
Research and
development
expenses, net 5,736 - 5,736 6,930 - 6,930
Selling, general
and administrative
expenses (2) 21,992 (400) 21,592 25,750 (400) 25,350
Operating income
(loss) (957) 988 31 526 1,809 2,335
Financial income
(expenses), net. 19 - 19 (80) - (80)
Taxes on Income (3) 949 (999) (50) 237 (358) (121)
Other (4) (41) 43 2 - - -
Net income (loss) (30) 32 2 683 1,451 2,134
Less: Net loss (gain)
attributable to the
noncontrolling interest 44 - 44 (*)41 - (*)41
Net income (loss)
attributable to
Cimatron's
shareholders $ 14 $ 32 $ 46 $ 724 $1,451 $ 2,175
Net income per share
- basic and diluted $ 0.00 $ 0.01 $ 0.08 $ 0.23
Weighted average
number of shares
outstanding
Basic EPS
(in thousands) 9,156 9,156 9,341 9,341
Diluted EPS
(in thousands) 9,156 9,156 9,360 9,360
(*) Reclassification due to the adoption of SFAS 160
(1) Non-GAAP adjustment related to Gibbs' assumed support contracts
that were not recognized on a GAAP basis in fiscal 2008 or thereafter
due to business combination accounting rules.
(2) Non-GAAP adjustment to exclude non-cash amortization of acquired
intangible assets.
(3) Non-GAAP adjustment to exclude the effect of deferred taxes.
(4) Non-GAAP adjustment to exclude loss from discontinued operations.
CIMATRON LIMITED
CONSOLIDATED BALANCE SHEETS
(US Dollars in thousands)
December 31, December 31,
2009 2008
ASSETS
CURRENT ASSETS:
Total cash, cash equivalents and
short-term investments $ 6,684 $ 5,727
Trade receivables 5,422 7,108
Other current assets 3,308 2,697
Total current assets 15,414 15,532
Deposits with insurance companies
and severance pay fund 2,935 2,719
Net property and equipment 1,046 1,312
Total other assets 13,285 14,307
Total assets $ 32,680 $ 33,870
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Short-term bank credit $ 456 $ 155
Trade payables 1,064 1,865
Accrued expenses and other liabilities 6,991 7,348
Deferred revenues 2,397 2,348
Total current liabilities 10,908 11,716
LONG-TERM LIABILITIES:
Accrued severance pay 4,104 3,933
Long-term loan 204 293
Deferred tax liability 1,365 1,729
Total long-term liabilities 5,673 5,955
Total shareholders' equity 16,099 (*)16,199
Total liabilities and shareholders' equity $ 32,680 $ 33,870
(*) Reclassification due to the adoption of SFAS 160
CIMATRON LIMITED
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(US Dollars in thousands)
Accumulated
Additional other
Non-controlling Share paid-in comprehensive
Interest capital capital income (loss)
Balance at
December 31, 2008 $ (4) $ 304 $ 18,131 $ 65
Changes during the
twelve months ended
December 31, 2009:
Net gain (loss) (44)
Unrealized loss on
derivative instruments (81)
Stock option
compensation 73
Investment in treasury
stock
Foreign currency
translation adjustment 91
Total comprehensive loss
Balance at
December 31, 2009 $ (48) $ 304 $ 18,204 $ 75
Retained
earnings Comprehensive Total
(accumulated Treasury income shareholders'
deficit) stock (loss) equity
Balance at
December 31, 2008 $ (1,908) $ (389) $ 16,199
Changes during the
twelve months ended
December 31, 2009:
Net gain (loss) 14 (30) (30)
Unrealized loss on
derivative instruments (81) (81)
Stock option
compensation 73
Investment in
treasury stock (153) (153)
Foreign currency
translation adjustment 91 91
Total comprehensive
loss (20)
Balance at
December 31, 2009 $ (1,894) $ (542) $ 16,099
CIMATRON LIMITED
STATEMENTS OF CASH FLOWS
(US Dollars in thousands)
Twelve months ended
December 31,
2009 2008
Cash flows from operating activities:
Net (loss) gain $ (30) (*)$ 683
Adjustments to reconcile net loss
to net cash provided by operating
activities:
Depreciation and amortization 1,575 1,584
Increase in accrued severance pay 138 4
Gain from sale of property and
equipment, net - (3)
Stock option compensation 73 115
Loss on disposal of businesses -
discontinued operations 43 -
Deferred taxes, net (984) (359)
Changes in assets and liabilities:
Increase in accounts receivable and
prepaid expenses 1,854 2,475
Decrease (increase) in inventory (15) 26
Increase in deposits with insurance
companies and severance pay fund (216) (16)
Decrease in trade payables, accrued
expenses and other liabilities (1,164) (1,739)
Net cash provided by operating
activities 1,274 2,770
Cash flows from investing activities:
Proceeds from sale of property and
equipment - 2
Proceeds from sale and redemption of bonds - 1,245
Purchase of property and equipment (262) (438)
Cash and cash equivalents disposed of
discontinued operations (46) -
Additional payment for acquisition of
subsidiary - (1,268)
Acquisition of newly-consolidated
subsidiaries (Appendix A) - (4,761)
Net cash used in investing activities (308) (5,220)
Cash flows from financing activities:
Short-term bank credit 301 (637)
Long-term bank credit (104) 4
Proceeds from issuance of shares upon
exercise of options - 14
Investment in treasury stock (153) (230)
Net cash provided (used) in financing
activities 44 (849)
Net increase (decrease) in cash and cash
equivalents 1,010 (3,299)
Effect of exchange rate changes on cash (53) -
Cash and cash equivalents at beginning of
period 5,727 9,026
Cash and cash equivalents at end of
period $ 6,684 $ 5,727
Appendix A - Acquisition of subsidiary, net of cash acquired
Working capital - excluding cash (879)
Goodwill 4,035
Other intangible assets 5,432
Property and equipment 158
Tax Asset 302
9,048
Issuance of shares (4,287)
$ 4,761
Appendix B - Non-cash transactions
Purchase of property on credit $ 10 $ 5
(*) Reclassification due to the adoption of SFAS 160
TraderPower Featured Companies
- Astrotech Corp. (NASDAQ: ASTC)
- Cepton Inc. (NASDAQ: CPTN)
- Clene Inc. (NASDAQ: CLNN)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)
- Freight Technologies Inc. (NASDAQ: FRGT)
- InMed Pharmaceuticals Inc. (NASDAQ: INM)
- Lexaria Bioscience Corp. (NASDAQ: LEXX)
- Mullen Automotive Inc. (NASDAQ: MULN)
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
Top Small Cap Market News
- $FNGR InvestorNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Agreements to Add Charging Terminal Access for Users of Growing Da Ge App
- $FRGT InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Appointed as Solave’s Logistics Solutions Provider for Cross-Border Operations
- $PXMD InvestorNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) in Process of Responding to Emergency Request for IV Suramin from African Health Ministry
- $CLNN InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple Sclerosis Treatment Presented at AAN Conference
- $RFLXF Malaysian Company to Transform Agricultural Waste into Graphite in Nevada
- $FNICF Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Sees Great Potential Across its Saskatchewan Nickel Projects
- $CIPI Green-Energy Projects Face Financing Woes Amid High Interest Rates
- $LGVN New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for ~$6.2M
- $SOBR InvestorNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Inks Deal with Four-Facility Behavioral Health Provider in Florida
- $APAAF InvestorNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Files NI 43-101 Technical Report for Goiás-Based PCH Ionic Adsorption Clay Project
Recent Posts
- $APAAF InvestorNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Files NI 43-101 Technical Report for Goiás-Based PCH Ionic Adsorption Clay Project
- $SOBR InvestorNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Inks Deal with Four-Facility Behavioral Health Provider in Florida
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for ~$6.2M
- $LGVN New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People
- $CIPI Green-Energy Projects Face Financing Woes Amid High Interest Rates
- $FNICF Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Sees Great Potential Across its Saskatchewan Nickel Projects
- $RFLXF Malaysian Company to Transform Agricultural Waste into Graphite in Nevada
- $CLNN InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple Sclerosis Treatment Presented at AAN Conference
Recent Comments
Archives
- April 2024
- January 2023
- June 2022
- December 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009